Outcomes of Children With BCR-ABL1–Like Acute Lymphoblastic Leukemia Treated With Risk-Directed Therapy Based on the Levels of Minimal Residual Disease
KG Roberts, D Pei, D Campana… - Journal of Clinical …, 2014 - ascopubs.org
Purpose BCR-ABL1–like acute lymphoblastic leukemia (ALL) is a recently identified B-cell
ALL (B-ALL) subtype with poor outcome that exhibits a gene expression profile similar to …
ALL (B-ALL) subtype with poor outcome that exhibits a gene expression profile similar to …
BCR-ABL (Ph)-like acute leukemia—pathogenesis, diagnosis and therapeutic options
Recent comprehensive genetic studies revealed numerous genetic aberrations underlying a
group of high-risk leukemias that share a specific activated kinase gene expression pattern …
group of high-risk leukemias that share a specific activated kinase gene expression pattern …
Beyond Philadelphia:'Ph-like'B cell precursor acute lymphoblastic leukemias–diagnostic challenges and therapeutic promises
S Izraeli - Current opinion in hematology, 2014 - journals.lww.com
Beyond Philadelphia: ‘Ph-like’ B cell precursor acute lympho... : Current Opinion in Hematology
Beyond Philadelphia: ‘Ph-like’ B cell precursor acute lymphoblastic leukemias – diagnostic …
Beyond Philadelphia: ‘Ph-like’ B cell precursor acute lymphoblastic leukemias – diagnostic …
Acute lymphoblastic leukemia
N Jain, S Faderl, HM Kantarjian… - Holland‐Frei Cancer …, 2016 - Wiley Online Library
Overview In adults, acute lymphoblastic leukemia (ALL) is a disease with poor prognosis. In
the last several years, there have been significant advances in understanding the disease …
the last several years, there have been significant advances in understanding the disease …
Sustained long-term remission with tyrosine kinase inhibitor therapy in treatment-refractory B-cell acute lymphoblastic leukemia harboring a RCSD1::ABL2 fusion …
MF Zahid, R Kainthla - Leukemia & Lymphoma, 2024 - Taylor & Francis
Acute lymphoblastic leukemia (ALL) is the most common form of leukemia in the pediatric
age group and carries a very good prognosis, with cure rates approaching 90%. however …
age group and carries a very good prognosis, with cure rates approaching 90%. however …
[HTML][HTML] CCLG-2008 方案治疗424 例儿童急性淋巴细胞白血病的疗效分析
郭霞， 朱易萍， 李强， 贾苍松， 陆晓茜… - Chinese Journal of …, 2017 - ncbi.nlm.nih.gov
CCLG-2008方案治疗424例儿童急性淋巴细胞白血病的疗效分析- PMC Back to Top Skip to
main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …
main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …
Philadelphia chromosome-negative acute lymphoblastic leukemia: therapies under development
SA Parikh, MR Litzow - Future Oncology, 2014 - Taylor & Francis
Although the prognosis of adults with Philadelphia chromosome-negative acute
lymphoblastic leukemia (ALL) has steadily improved over the past decade, less than 50% of …
lymphoblastic leukemia (ALL) has steadily improved over the past decade, less than 50% of …
Pokroky v léčbě akutní lymfoblastické leukemie dospělých.
Š Hrabovský, F Folber, C Šálek… - … Today/Transfuze a …, 2015 - search.ebscohost.com
1Interní hematologická a onkologická klinika, LF MU a FN Brno 2Středoevropský
technologický institut (CEITEC), LF MU Brno 3Ústav hematologie a krevní transfuze, Praha …
technologický institut (CEITEC), LF MU Brno 3Ústav hematologie a krevní transfuze, Praha …
Therapeutic outcomes of CCLG-2008 protocol in the treatment of 424 childhood acute lymphoblastic leukemia
X Guo, YP Zhu, Q Li, CS Jia, XX Lu, X Yang… - Zhonghua xue ye xue …, 2017 - europepmc.org
[Therapeutic outcomes of CCLG-2008 protocol in the treatment of 424 childhood acute
lymphoblastic leukemia]. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …
lymphoblastic leukemia]. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …
Molecular Biology of Leukemias
LJ Medeiros, SN Konoplev - The Molecular Basis of Human Cancer, 2017 - Springer
Normal hematopoiesis is a meticulously controlled process of cell division and differentiation
arising from hematopoietic stem cells with self-renewal capacity. This process is regulated …
arising from hematopoietic stem cells with self-renewal capacity. This process is regulated …